{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:48:23Z","timestamp":1792806503287,"version":"4.5.0"},"reference-count":141,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21wm0425019"],"award-info":[{"award-number":["JP21wm0425019"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005694","name":"Hori Sciences And Arts Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","award":["6\\u20138"],"award-info":[{"award-number":["6\\u20138"]}],"id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Government of Japan Ministry of Health Labour and Welfare","doi-asserted-by":"publisher","award":["JPMH23FC1008"],"award-info":[{"award-number":["JPMH23FC1008"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019770","name":"National Institutes of Natural Sciences Exploratory Research Center on Life and Living Systems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007312","name":"National Center for Geriatrics and Gerontology","doi-asserted-by":"publisher","award":["24-20"],"award-info":[{"award-number":["24-20"]}],"id":[{"id":"10.13039\/501100007312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007312","name":"National Center for Geriatrics and Gerontology","doi-asserted-by":"publisher","award":["21-13"],"award-info":[{"award-number":["21-13"]}],"id":[{"id":"10.13039\/501100007312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030953","name":"Tokyo Metropolitan Institute for Geriatrics and Gerontology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030953","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K27499"],"award-info":[{"award-number":["JP23K27499"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22H04923"],"award-info":[{"award-number":["JP22H04923"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.celrep.2025.116203","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T14:36:42Z","timestamp":1756823802000},"page":"116203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Biomarker-related phospho-tau217 appears in synapses around A\u03b2 plaques prior to tau tangle in cerebral cortex of preclinical Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"44","author":[{"given":"Yu","family":"Hirota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terunori","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manato","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8275-8293","authenticated-orcid":false,"given":"Michiko","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi M.","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2025.116203_bib1","series-title":"Global Action Plan on the Public Health Response to Dementia 2017-2025","year":"2017"},{"key":"10.1016\/j.celrep.2025.116203_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.celrep.2025.116203_bib3","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2025.116203_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2025.116203_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.116203_bib6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","article-title":"A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease","volume":"26","author":"Barthelemy","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116203_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.celrep.2025.116203_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.116203_bib9","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116203_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-020-02195-x","article-title":"Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline","volume":"140","author":"Lantero Rodriguez","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2025.116203_bib11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jalz.2019.09.079","article-title":"Tau-positron emission tomography correlates with neuropathology findings","volume":"16","author":"Lowe","year":"2020","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2025.116203_bib12","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.celrep.2025.116203_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","article-title":"Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study","volume":"17","author":"Gordon","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib14","doi-asserted-by":"crossref","first-page":"e1295","DOI":"10.1212\/WNL.0000000000006277","article-title":"Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease","volume":"91","author":"McDade","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2025.116203_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mcn.2018.12.001","article-title":"Biomarkers for tau pathology","volume":"97","author":"Scholl","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.celrep.2025.116203_bib17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","article-title":"CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study","volume":"60","author":"Strozyk","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2025.116203_bib18","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1212\/WNL.0b013e3181bc010c","article-title":"Relationships between biomarkers in aging and dementia","volume":"73","author":"Jagust","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2025.116203_bib19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer's disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib20","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jamaneurol.2014.1358","article-title":"Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid beta-amyloid 42: a cross-validation study against amyloid positron emission tomography","volume":"71","author":"Palmqvist","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib22","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jalz.2018.07.220","article-title":"Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease","volume":"14","author":"Shaw","year":"2018","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2025.116203_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","article-title":"Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?","volume":"26","author":"Blennow","year":"1995","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.celrep.2025.116203_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0140-6736(85)90074-1","article-title":"Paired helical filament antigen in CSF","volume":"2","author":"Mehta","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2025.116203_bib25","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1471-4159.1993.tb09823.x","article-title":"Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay","volume":"61","author":"Vandermeeren","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.celrep.2025.116203_bib26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.410220412","article-title":"Alzheimer-related neuronal protein A68: specificity and distribution","volume":"22","author":"Wolozin","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-beta biomarkers for Alzheimer's disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116203_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology","volume":"141","author":"Ashton","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2025.116203_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jamaneurol.2023.4596","article-title":"Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies","volume":"81","author":"Mattsson-Carlgren","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","article-title":"Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography","volume":"14","author":"Mielke","year":"2018","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2025.116203_bib32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2025.116203_bib33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13024-017-0206-8","article-title":"Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome","volume":"12","author":"Tatebe","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.celrep.2025.116203_bib34","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/alz.13542","article-title":"Plasma Abeta42\/Abeta40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease","volume":"20","author":"Rissman","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2025.116203_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","article-title":"Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization","volume":"285","author":"Vanmechelen","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.celrep.2025.116203_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fnagi.2019.00121","article-title":"Tau Phosphorylation Rates Measured by Mass Spectrometry Differ in the Intracellular Brain vs. Extracellular Cerebrospinal Fluid Compartments and Are Differentially Affected by Alzheimer's Disease","volume":"11","author":"Barthelemy","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.celrep.2025.116203_bib37","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41467-020-15436-0","article-title":"Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease","volume":"11","author":"Janelidze","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116203_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(00)01178-2","article-title":"Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients","volume":"287","author":"Kohnken","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.celrep.2025.116203_bib39","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","article-title":"Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study","volume":"20","author":"Thijssen","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib40","doi-asserted-by":"crossref","first-page":"e3026","DOI":"10.1212\/WNL.0000000000010814","article-title":"Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias","volume":"95","author":"Hanes","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2025.116203_bib41","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s00415-023-12148-5","article-title":"Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort","volume":"271","author":"Mendes","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib42","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/alz.12841","article-title":"Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays","volume":"19","author":"Ashton","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2025.116203_bib43","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","article-title":"Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests","volume":"30","author":"Barthelemy","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116203_bib44","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012921","article-title":"Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Abeta pathology are detected","volume":"12","author":"Suarez-Calvet","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.celrep.2025.116203_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz2387","article-title":"Abeta deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease","volume":"6","author":"Mattsson-Carlgren","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2025.116203_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamaneurol.2020.4201","article-title":"Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib47","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202217123","article-title":"Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads","volume":"15","author":"Salvado","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.celrep.2025.116203_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad113","article-title":"Predictive blood biomarkers and brain changes associated with age-related cognitive decline","volume":"5","author":"Saunders","year":"2023","journal-title":"Brain Commun."},{"key":"10.1016\/j.celrep.2025.116203_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40478-021-01307-2","article-title":"Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels","volume":"10","author":"Wennstrom","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.celrep.2025.116203_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-023-02594-w","article-title":"Plasma biomarkers for prediction of Alzheimer's disease neuropathologic change","volume":"146","author":"Bermudez","year":"2023","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2025.116203_bib51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13024-022-00578-0","article-title":"Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels","volume":"17","author":"Murray","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.celrep.2025.116203_bib52","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/alz.12749","article-title":"Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain","volume":"19","author":"Moloney","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2025.116203_bib53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s40478-020-01019-z","article-title":"Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain","volume":"8","author":"Horie","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.celrep.2025.116203_bib54","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ana.24517","article-title":"Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue","volume":"78","author":"Marquie","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib55","first-page":"764","article-title":"Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies","volume":"140","author":"Ono","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.celrep.2025.116203_bib56","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.neuron.2022.03.034","article-title":"Regional Abeta-tau interactions promote onset and acceleration of Alzheimer's disease tau spreading","volume":"110","author":"Lee","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116203_bib57","first-page":"1797","article-title":"Plasma p-tau231 and p-tau217 as state markers of amyloid-beta pathology in preclinical Alzheimer's disease","volume":"28","author":"Mila-Aloma","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116203_bib58","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jamaneurol.2022.4485","article-title":"Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography","volume":"80","author":"Therriault","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib59","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.celrep.2025.116203_bib60","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2025.116203_bib61","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s40478-020-00967-w","article-title":"Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies","volume":"8","author":"Xia","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.celrep.2025.116203_bib62","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40478-017-0458-0","article-title":"Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau","volume":"5","author":"Strang","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.celrep.2025.116203_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103836","article-title":"Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease","volume":"76","author":"Ashton","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.celrep.2025.116203_bib64","doi-asserted-by":"crossref","first-page":"e1681","DOI":"10.1212\/WNL.0000000000012727","article-title":"Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays","volume":"97","author":"Leuzy","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2025.116203_bib65","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40478-020-01117-y","article-title":"Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease","volume":"9","author":"Bengoa-Vergniory","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.celrep.2025.116203_bib66","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s004010100423","article-title":"Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease","volume":"103","author":"Augustinack","year":"2002","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2025.116203_bib67","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1046\/j.1471-4159.1997.69052087.x","article-title":"A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease","volume":"69","author":"Jicha","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.celrep.2025.116203_bib68","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.neurobiolaging.2007.02.016","article-title":"Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia","volume":"29","author":"Engelborghs","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.celrep.2025.116203_bib69","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","article-title":"Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF","volume":"52","author":"Hulstaert","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2025.116203_bib70","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib71","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac286","article-title":"Distinct brain pathologies associated with Alzheimer's disease biomarker-related phospho-tau 181 and phospho-tau 217 in App knock-in mouse models of amyloid-beta amyloidosis","volume":"4","author":"Hirota","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.celrep.2025.116203_bib72","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3233\/JAD-230121","article-title":"Alzheimer's Disease-Related Phospho-Tau181 Signals Are Localized to Demyelinated Axons of Parvalbumin-Positive GABAergic Interneurons in an App Knock-In Mouse Model of Amyloid-beta Pathology","volume":"93","author":"Hirota","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.celrep.2025.116203_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/science.1255263","article-title":"Interneurons. Fast-spiking, parvalbumin(+) GABAergic interneurons: from cellular design to microcircuit function","volume":"345","author":"Hu","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116203_bib74","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuron.2016.06.033","article-title":"GABAergic Interneurons in the Neocortex: From Cellular Properties to Circuits","volume":"91","author":"Tremblay","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116203_bib75","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/jnc.13447","article-title":"Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system","volume":"139","author":"Feinstein","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.celrep.2025.116203_bib76","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41583-020-0360-9","article-title":"Locus coeruleus: a new look at the blue spot","volume":"21","author":"Poe","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.celrep.2025.116203_bib77","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrn2573","article-title":"The locus coeruleus and noradrenergic modulation of cognition","volume":"10","author":"Sara","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.celrep.2025.116203_bib78","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JAD-142682","article-title":"Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis","volume":"46","author":"Theofilas","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.celrep.2025.116203_bib79","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/0269881113490326","article-title":"Functional neuroanatomy of the central noradrenergic system","volume":"27","author":"Szabadi","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.celrep.2025.116203_bib80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainres.2017.12.027","article-title":"Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer's disease pathogenesis: Potential strategies to protect the LC against aging","volume":"1702","author":"Satoh","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.celrep.2025.116203_bib81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tins.2018.01.010","article-title":"Long Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease","volume":"41","author":"Weinshenker","year":"2018","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.celrep.2025.116203_bib82","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00401-020-02248-1","article-title":"The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer's disease","volume":"141","author":"Matchett","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2025.116203_bib83","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3233\/JAD-210191","article-title":"The Locus Coeruleus in Aging and Alzheimer's Disease: A Postmortem and Brain Imaging Review","volume":"83","author":"Beardmore","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.celrep.2025.116203_bib84","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/alz.12192","article-title":"Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease","volume":"17","author":"Arnsten","year":"2021","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2025.116203_bib85","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1021\/bi981874p","article-title":"Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments","volume":"38","author":"Schneider","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.celrep.2025.116203_bib86","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","article-title":"Dendritic Tau in Alzheimer's Disease","volume":"99","author":"Ittner","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116203_bib87","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.celrep.2025.116203_bib88","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.neuron.2018.02.015","article-title":"Tau Kinetics in Neurons and the Human Central Nervous System","volume":"97","author":"Sato","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116203_bib89","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.neuron.2023.04.020","article-title":"Synaptic oligomeric tau in Alzheimer's disease - A potential culprit in the spread of tau pathology through the brain","volume":"111","author":"Colom-Cadena","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116203_bib90","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","article-title":"Protein transmission in neurodegenerative disease","volume":"16","author":"Peng","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib91","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1523\/JNEUROSCI.4261-13.2014","article-title":"Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers","volume":"34","author":"Frandemiche","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.celrep.2025.116203_bib92","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/j.1460-2075.1995.tb07116.x","article-title":"Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform","volume":"14","author":"Gotz","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2025.116203_bib93","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116203_bib94","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.15252\/embj.201797724","article-title":"Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn-mediated local protein translation","volume":"36","author":"Li","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2025.116203_bib95","doi-asserted-by":"crossref","first-page":"32040","DOI":"10.1074\/jbc.M112.401240","article-title":"Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation","volume":"287","author":"Mondragon-Rodriguez","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2025.116203_bib96","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/glia.23074","article-title":"Microglia contributes to plaque growth by cell death due to uptake of amyloid beta in the brain of Alzheimer's disease mouse model","volume":"64","author":"Baik","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.celrep.2025.116203_bib97","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","article-title":"Microglia use TAM receptors to detect and engulf amyloid beta plaques","volume":"22","author":"Huang","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116203_bib98","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nn.4132","article-title":"Depletion of microglia and inhibition of exosome synthesis halt tau propagation","volume":"18","author":"Asai","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2025.116203_bib99","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-021-00440-9","article-title":"Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model","volume":"16","author":"Clayton","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.celrep.2025.116203_bib100","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.celrep.2018.07.072","article-title":"Living Neurons with Tau Filaments Aberrantly Expose Phosphatidylserine and Are Phagocytosed by Microglia","volume":"24","author":"Brelstaff","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.116203_bib101","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/glia.23270","article-title":"Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease","volume":"66","author":"Gomez-Arboledas","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.celrep.2025.116203_bib102","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11481-012-9427-3","article-title":"Amyloid-beta-induced astrocytic phagocytosis is mediated by CD36, CD47 and RAGE","volume":"8","author":"Jones","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.celrep.2025.116203_bib103","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/glia.23943","article-title":"Amyloid-beta impairs the phagocytosis of dystrophic synapses by astrocytes in Alzheimer's disease","volume":"69","author":"Sanchez-Mico","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.celrep.2025.116203_bib104","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s43587-022-00281-1","article-title":"Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer's disease mouse models","volume":"2","author":"Dejanovic","year":"2022","journal-title":"Nat. Aging"},{"key":"10.1016\/j.celrep.2025.116203_bib105","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jamaneurol.2023.3530","article-title":"Tau Oligomer-Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease","volume":"80","author":"Taddei","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib106","article-title":"Human astrocytes and microglia show augmented ingestion of synapses in Alzheimer's disease via MFG-E8","volume":"4","author":"Tzioras","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2025.116203_bib107","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41593-018-0298-7","article-title":"A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology","volume":"22","author":"Fu","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2025.116203_bib108","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41380-023-02113-z","article-title":"Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer's disease? From preclinical studies to the clinical trials","volume":"28","author":"Basheer","year":"2023","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.celrep.2025.116203_bib109","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114022","article-title":"Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau","volume":"13","author":"Mattsson-Carlgren","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.celrep.2025.116203_bib110","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/jamaneurol.2022.3392","article-title":"Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial","volume":"79","author":"Pontecorvo","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib111","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2025.116203_bib112","article-title":"Donanemab exposure and efficacy relationship using modeling in Alzheimer's disease","volume":"9","author":"Gueorguieva","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2025.116203_bib113","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00401-021-02400-5","article-title":"CSF p-tau increase in response to Abeta-type and Danish-type cerebral amyloidosis and in the absence of neurofibrillary tangles","volume":"143","author":"Kaeser","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2025.116203_bib114","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1002\/alz.12892","article-title":"Localization, induction, and cellular effects of tau phosphorylated at threonine 217","volume":"19","author":"Rajbanshi","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2025.116203_bib115","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.neuron.2024.02.017","article-title":"P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy","volume":"112","author":"Zhang","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116203_bib116","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1002\/alz.13737","article-title":"Nanoscale imaging of pT217-tau in aged rhesus macaque entorhinal and dorsolateral prefrontal cortex: Evidence of interneuronal trafficking and early-stage neurodegeneration","volume":"20","author":"Datta","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2025.116203_bib117","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/archneurol.2009.279","article-title":"Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report","volume":"66","author":"Cairns","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib118","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nicl.2013.03.014","article-title":"Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease","volume":"2","author":"Vandenberghe","year":"2013","journal-title":"Neuroimage. Clin."},{"key":"10.1016\/j.celrep.2025.116203_bib119","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1093\/brain\/awab434","article-title":"11C-PiB PET can underestimate brain amyloid-beta burden when cotton wool plaques are numerous","volume":"145","author":"Abrahamson","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.celrep.2025.116203_bib120","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib121","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00401-018-1948-2","article-title":"Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease","volume":"137","author":"Cicognola","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2025.116203_bib122","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/neuro.05.028.2009","article-title":"Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques","volume":"3","author":"Garcia-Marin","year":"2009","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.celrep.2025.116203_bib123","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.neurobiolaging.2007.04.010","article-title":"Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease","volume":"29","author":"Kashani","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.celrep.2025.116203_bib124","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1471-4159.2006.03935.x","article-title":"Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease","volume":"98","author":"Kirvell","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.celrep.2025.116203_bib125","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/ene.15043","article-title":"Inhibitory synapse loss and accumulation of amyloid beta in inhibitory presynaptic terminals in Alzheimer's disease","volume":"29","author":"Kurucu","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101372","article-title":"Neuronal excitation\/inhibition imbalance: core element of a translational perspective on Alzheimer pathophysiology","volume":"69","author":"Maestu","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.celrep.2025.116203_bib127","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2025.116203_bib128","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.celrep.2025.116203_bib129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13195-022-01041-4","article-title":"A multiscale brain network model links Alzheimer's disease-mediated neuronal hyperactivity to large-scale oscillatory slowing","volume":"14","author":"van Nifterick","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.celrep.2025.116203_bib130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00401-022-02526-0","article-title":"Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer's disease neuropathologic change","volume":"145","author":"Scaduto","year":"2023","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2025.116203_bib131","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41593-018-0080-x","article-title":"Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer's disease","volume":"21","author":"Styr","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2025.116203_bib132","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114408","article-title":"Blood-based biomarkers for Alzheimer's disease","volume":"14","author":"Leuzy","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.celrep.2025.116203_bib133","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jamaneurol.2022.5272","article-title":"Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers","volume":"80","author":"Mattsson-Carlgren","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib134","doi-asserted-by":"crossref","first-page":"802","DOI":"10.14283\/jpad.2024.122","article-title":"Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies","volume":"11","author":"Sperling","year":"2024","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.celrep.2025.116203_bib135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116203_bib136","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/NEN.0b013e318186de48","article-title":"Lewy body pathology involves cutaneous nerves","volume":"67","author":"Ikemura","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib137","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1440-1789.2007.00806.x","article-title":"Neuropathology of mild cognitive impairment","volume":"27","author":"Saito","year":"2007","journal-title":"Neuropathology"},{"key":"10.1016\/j.celrep.2025.116203_bib138","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jnen\/63.9.911","article-title":"Staging of argyrophilic grains: an age-associated tauopathy","volume":"63","author":"Saito","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.celrep.2025.116203_bib139","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1440-1789.2004.00571.x","article-title":"Neuropathological diagnostic criteria for Alzheimer's disease","volume":"24","author":"Murayama","year":"2004","journal-title":"Neuropathology"},{"key":"10.1016\/j.celrep.2025.116203_bib140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40478-015-0215-1","article-title":"Incidence and extent of TDP-43 accumulation in aging human brain","volume":"3","author":"Uchino","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.celrep.2025.116203_bib141","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","article-title":"A Threshold Selection Method from Gray-Level Histograms","volume":"9","author":"Otsu","year":"1979","journal-title":"IEEE Trans. Syst. Man Cybern."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221112472500974X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221112472500974X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:48:53Z","timestamp":1790138933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221112472500974X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":141,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S221112472500974X"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116203","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarker-related phospho-tau217 appears in synapses around A\u03b2 plaques prior to tau tangle in cerebral cortex of preclinical Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116203"}}